Purpurogallin inhibits dna synthesis of murine fibrosarcoma L-929 and human U-87 mg glioblastoma cells in vitro

Chemotherapy

Volumn 42, Issue 3, 1996, Pages 199-205

  Fung, Kwok Pui ^a,b   Wu, Tai Wing ^a   Lui, Chi Pang ^b  

^a UNIVERSITY OF TORONTO   (Canada)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

DNA; Purpurogallin; Tumour cell

Indexed keywords

FLAVONOID; PURPUROGALLIN; TROLOX C; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; DNA SYNTHESIS INHIBITION; FIBROSARCOMA; GLIOBLASTOMA; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; TUMOR CELL LINE;

EID: 0029874002     PISSN: 00093157     EISSN: 14219794     Source Type: Journal    
DOI: 10.1159/000239442     Document Type: Article

References (30)

1. Ames BN, Shigcnaga MK, Hagen TM: Oxidants, antioxidants, and the degenerative diseases of aging. Proc Natl Acad Sei USA 1993:90:7915-7922.
2. Feig DI, Reid TM, Loeb LA: Reactive oxygen species in tumorigene-sis. Cancer Res 1994:54:1890s-1894s.
3. Byers T, Perry G: Dietary' carotenes, vitamin C, and vitamin E as protective antioxidants in human cancers. Annu Rev Nutr 1992;12:139-159.
4. Prasad KN, Edwards-Prasad J: Vitamin E and cancer prevention: Recent advances and future potentials. J Am Coll Nutr 1992:11:487-500.
5. Bostik RM, Potter JD, McKenzie DR, Sellers TA, Kushi LH, Steinmetz KA, Folsom AR: Reduced risk of colon cancer with high intake of vitamin E: The Iowa Women's Health Study. Cancer Res 1993:53: 4230-4237.
6. Garland M, Willett WC, Manson JE, Hunter DJ: Antioxidant micro-nutrients and breast cancer. J Am CollNutr 1993;12:400-411.
7. Blot WJ, Li J-Y, Taylor PR, Guo W, Dawsey S, Wang GQ, Yang CS, Zheng SF, Gail M, Li GY: Nutrition intervention trials in Linxian, China: Supplementation with specific vitamin/mineral combinations, cancer incidence, and disease-specific mortality in the general population. J Natl Cancer Inst 1993:85:1483-1492.
8. Longnccker MP, Martin-Moreno J-M, Knekt P, Nomura AM, Schobcr SE, Stahelin HB, Wald NJ, Gey KF, Willett WC: Scrum alpha-tocopher-ol concentration in relation to subsequent colorectal cancer: Pooled data from five cohorts. J Natl Cancer Inst 1992:84:430-435.
9. Comstock GW, Bush TL, Hclzl-souer K: Serum retinol, beta-caro-tcnc, vitamin E, and selenium as related to subsequent cancer of specific sites. Am J Epidemiol 1992; 135:115-121.
10. Kumar K, Thangaraju M, Sachda-nandam P: Changes observed in antioxidant system in the blood of postmenopausal women with breast cancer. Biochem Int 1991;25:371-380.
11. Punnonen R, Kudo R, Punnonen K, Hietanen E, Kuoppala T, Kainu-laincn H, Sato K, Ahotupa M: Activities of antioxidant enzymes and lipid peroxidation in endometrial cancer. Eur J Cancer 1993;29:266-269.
12. Chen J, Gcissler C, Parpia B, Li J, Campbell TC: Antioxidant status and cancer mortality in China. Int J Epidemiol 1992;21:625-635.
13. Jaakkola M, Lahteenmaki P, Laakso J, Harju E, Tykka H, Mahlbcrg K: Treatment with antioxidant and other nutrients in combination with chemotherapy and irradiation in patients with small-cell lung cancer. Anticanccr Res 1992;12:599-606.
14. Wu TW, Hashimoto N, Wu J, Carey D, Li RK, Mickle DAG, Weisel RD: The cytoprotcctivc effect of Trolox demonstrated with three types of human cells. Biochem Cell Biol 1990;68:1189-1194.
15. Wu TW, Au JX, Wu J, Mickle DAG, Carey D: Trolox protects rat hepatocytes against oxyradical damage and the ischemic rat liver from repcrfusion injury. Hcpatology 1991;13:575-580.
16. Zielenski J, Wu TW, Fung KP, Zeng LH, Li RK, Mickle DAG, Wu J: Chemical syntheses ofTrolox conjugates which protect human ventricular myocytes against in situ-generated oxyradicals. Eur J Pharmacol 1993;248:313-318.
17. Wu TW, Wu J, Zeng LH, Sugiyama H, Mickle DA, Au JX: Reduction of experimental myocardial infarct size by infusion of lactosylphenyl-Trolox. Cardiovasc Res 1993;27: 736-739.
18. Wu TW, Wu J, Carey D, Zeng LH: Purpurogallin protects both ventricular myocytes and aortic endothelial cells of rats against oxyradical damage. Biochcm Cell Biol 1992,70: 803-809.
19. Sugiyama H, Fung KP, Wu TW: Purpurogallin is an antioxidant protector ofhuman erythrocytes against lysis by peroxyl radicals. Life Sci 1993;53:PL39-43.
20. Wu TW, Wu J, Zeng LH, Au JX, Carey D, Fung KP: Purpurogallin: In vivo evidence of a novel and effective cardioprotcctor. Life Sci 1994;54:PL23-28.
21. Fung KP, Ng SW, Choy YM: The reversal of effects of methotrexate on toxicity and glucose transport reduction by thymidine in Ehrlich ascites tumor bearing mice. Cancer Biochem Biophys 1986;8:249-256.
22. Wiseman H: Vitamin D is a membrane antioxidant. Ability to inhibit iron-dependent lipid peroxidation in liposomes compared to cholesterol, ergosterol and tamoxifen and relevance to anticancer action. FEBS Lett 1993:326:285-288.
23. Wiseman H, Smith C, Halliwell B, Cannon M, Arnstein HRV, Lcnnard MS: Droloxifene has membrane antioxidant ability: Potential relevance to its mechanism of therapeutic action in breast cancer. Cancer Lett 1992;66:61-68.
24. Wiseman H, Cannon M, Arnstein HRV, Barlow DJ: The structural mimicry of membrane sterols by tamoxifen: Evidence from cholesterol coefficients and molecular modelling for its action as a membrane antioxidant and an anticancer agent. Biochim Biophys Acta 1992,1138: 197-202.
25. Tarabolctti G, Perin L, Bottazzi B: Membrane fluidity affects tumourcell motility, invasion and lung-colonizing potential. Int J Cancer 1989;44:707-713.
26. Grunicke HH: The cell membrane as a target for cancer chemotherapy. Eur J Cancer 1991;27:281-284.
27. Das M, Singh SV, Mukhtar H, Awasthi YC: Differential inhibition of rat and human glutathione S-transferase isoenzymes by plant phenol. Biochem Biophys Res Com-mun 1986;141:1170-1176.
28. Klopman G, Dimayuga ML: Computer-automated structure evaluation of flavonoids and other structurally related compounds as glyox-alase I enzyme inhibitors. Am Soc Pharmacol Exp Ther 1988:34:218-222.
29. Barnard JF, Honck JF: Investigation on glyoxalase I inhibitors. Biochem Biophys Res Commun 1989; 165:118-124.
30. Schenk H, Klein M, Erdbruggcr W, Droge W, Schulze-Osthoff K: Distinct effects of thioredoxin and antioxidants on the activation of transcription factors NF-kB and AP-1. Proc Natl Acad Sci USA 1994;91: 1672-1676.